健脾利水方治疗失代偿期肝硬化55例疗效和安全性研究

doi:10.3969/j.issn.1672-5069.2016.06.026

Abstract

Pei Qifu，Li Hua.. Efficacy and safety of spironolacton, glycyrrhizin and herbal medicine in treatment of patients with cirrhosis and ascites[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 730-731.

[1] 刘彩峰，汪明明，李新立，等. 托伐普坦治疗肝硬化顽固性腹水并低钠血症的疗效. 山东大学学报（医学版），2016，54（1）:33-37.
[2] 田秋菊，贾继东. 肝硬化腹水及其相关并发症治疗新进展. 实用肝脏病杂志，2015，18（1）:1-3.
[3] 祝峻峰，钱平安，范兴良，等. 消水方联合托伐普坦治疗肝炎肝硬化顽固性腹水临床研究.实用肝脏病杂志，2016，19（2）:192-195.
[4] 肖丽，杨玲.肝硬化难治性腹水的诊治与血管收缩药物的应用.实用肝脏病杂志，2015，18（5）:460-462.
[5] 舒盼，崔丽安. 中医药治疗肝硬化腹水体会.中医杂志，2012，53（22）:1963-1964.
[6] 李岚，厉有名. 肝硬化顽固性腹水的治疗. 中国实用内科杂志，2013，33（9）:676-678.
[7] 孙良秀. 中西医结合治疗乙肝肝硬化顽固性腹水.中国实验方剂学杂志，2012，18（4）:252-253.
[8] 童芳芳.肝硬化并发自发性细菌性腹膜炎患者血清与腹水TNF-α、IL-6和IL-8水平差异比较.实用肝脏病杂志，2015，18（2）:191-192.
[9] 石光英，袁泽，杨丽丽，等. 奥曲肽治疗肝硬化合并顽固性腹水的Meta分析. 世界华人消化杂志，2015，23（27）:4411-4417.
[10] 戴丽岩，谢德武.恩替卡韦丹参螺内酯联合治疗乙肝后肝硬化腹水临床报告.中国实用内科杂志，2014，34（S1）:145-146.
[11] 吴世馨，何行春，陈梅，等. 综合护理干预配合内科综合治疗和腹腔穿刺治疗肝硬化顽固性腹水的临床效果.世界华人消化杂志，2015，23（7）:1154-1158.
[12] 吴素英，唐绍军.甘露醇联合速尿治疗难治性肝硬化腹水的疗效.中国老年学杂志，2013，33（8）:1920-1921.
[13] 李延玲，翟玉峰，张怀宏，等. 中医综合疗法治疗脾肾阳虚水停证肝硬化腹水60例临床观察.中国实验方剂学杂志，2015，21（16）:179-182.
[14] 季昆明，赵国达.健脾柔肝消水方治疗肝硬化腹水108例. 上海中医药杂志，2001，35（7）:25-25.
[15] 李勇华. 中西医结合治疗乙肝肝硬化腹水22例临床观察. 时珍国医国药，2014，25（1）:123-125.

Efficacy and safety of spironolacton, glycyrrhizin and herbal medicine in treatment of patients with cirrhosis and ascites

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[3]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[4]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[5]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[6]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[7]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[8]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[9]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[10]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[11]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[12]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[13]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[14]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[15]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.